It’s possible that the plasma of recovered COVID-19 patients may have antibodies that could help in the treatment of others with COVID-19.
Nurses and other participants from a range of disciplines will work in teams to devise answers, develop prototypes and pitch solutions.
A recently completed pilot program at CHOC and other California clinical sites helped target a baby’s specific genetic disease in just days.
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
CHOC, University Lab Partners establish unique training program for the next generation of biotech innovators
A joint effort from CHOC and ULP is aimed at inspiring Orange County high school students to become the next generation of biotech innovators.
Asymptomatic healthcare workers in a community with a low COVID-19 prevalence who undergo daily screenings are unlikely to be carriers.